Sustainability Report

Overview

The report presents Blueprint Medicines' first Materiality Assessment and a governance model in which the full board, Nominating and Corporate Governance Committee and ESG Steering Committee oversee sustainability. It reports 653 employees globally, with women comprising 57% of the workforce and 30% of the board. Environmental highlights include recycling 1,671 pounds of plastic from the Cambridge lab in 2023, while the company says it is still tracking broader environmental metrics. The report aligns disclosures with SASB Standards and maps activities to SDGs 3, 4, 9 and 10.

Document

Report type: Sustainability Report
Class: Dedicated
Scope: Full report
Fiscal year: 2023
Period: 1 January 2023 – 31 December 2023
Language: English
Pages
File size

Reporting standards, commitments and assurance details are available with a free account.

Standards

GRI
SASB
TCFD
ISSB
ESRS
Integrated Reporting Framework
GHG Protocol
EU Taxonomy
CDP
Other

Materiality

Assessment
Basis
Matrix

Assurance

Statement included

Data Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services